|
Q3 2026
|
347 |
448,127
|
JCPB, VGT, AAPL, NVDA
|
13F-HR
|
10/21/2026 |
000135252626000005 |
|
Q2 2026
|
349 |
448,177
|
JCPB, VGT, AMAT, JPSE
|
13F-HR
|
7/24/2026 |
000135252626000004 |
|
Q1 2026
|
344 |
392,420
|
JCPB, JPSE, AAPL, VGT
|
13F-HR
|
4/15/2026 |
000135252626000003 |
|
Q4 2025
|
338 |
384,884
|
JCPB, AAPL, VGT, JPSE
|
13F-HR
|
1/21/2026 |
000135252626000001 |
|
Q3 2025
|
340 |
377,623
|
JCPB, AAPL, VGT, JPSE
|
13F-HR
|
10/27/2025 |
000135252625000009 |
|
Q2 2025
|
347 |
365,732
|
JCPB, JPSE, JMUB, MSFT
|
13F-HR
|
7/31/2025 |
000135252625000004 |
|
Q1 2025
|
359 |
484,391
|
JCPB, MSFT, JMUB, AAPL
|
13F-HR
|
4/21/2025 |
000135252625000002 |
|
Q4 2024
|
377 |
488,227
|
JCPB, MSFT, AAPL, JMUB
|
13F-HR
|
1/23/2025 |
000135252625000001 |
|
Q3 2024
|
380 |
489,300
|
JCPB, MSFT, AAPL, LLY
|
13F-HR
|
10/28/2024 |
000135252624000004 |
|
Q2 2024
|
395 |
466,279
|
JCPB, MSFT, LLY, AAPL
|
13F-HR
|
8/9/2024 |
000135252624000003 |
|
Q1 2024
|
382 |
473,643
|
JCPB, MSFT, LLY, DAUG
|
13F-HR
|
4/24/2024 |
000135252624000002 |
|
Q4 2023
|
391 |
441,428
|
JCPB, MSFT, AAPL, DAUG
|
13F-HR
|
1/29/2024 |
000135252624000001 |
|
Q3 2023
|
390 |
391,602
|
MSFT, DAUG, AAPL, COST
|
13F-HR
|
10/24/2023 |
000135252623000004 |
|
Q2 2023
|
367 |
404,622
|
MSFT, AAPL, DAUG, CSX
|
13F-HR
|
7/26/2023 |
000135252623000003 |
|
Q1 2023
|
379 |
386,720
|
MSFT, AAPL, DAUG, CSX
|
13F-HR
|
4/25/2023 |
000135252623000002 |
|
Q4 2022
|
376 |
378,124
|
MSFT, DAUG, CSX, AAPL
|
13F-HR
|
2/1/2023 |
000135252623000001 |
|
Q3 2022
|
378 |
340,266
|
MSFT, AAPL, CSX, COST
|
13F-HR
|
10/25/2022 |
000135252622000004 |
|
Q2 2022
|
386 |
360,691
|
MSFT, AAPL, CSX, COST
|
13F-HR
|
7/21/2022 |
000135252622000003 |
|
Q1 2022
|
385 |
414,552
|
MSFT, AAPL, CSX, COST
|
13F-HR
|
5/5/2022 |
000135252622000002 |
|
Q4 2021
|
358 |
430,070
|
MSFT, AAPL, CSX, JPM
|
13F-HR
|
1/27/2022 |
000135252622000001 |
|
Q3 2021
|
391 |
393,029
|
MSFT, ARKQ, JPM, AAPL
|
13F-HR
|
10/29/2021 |
000135252621000004 |
|
Q2 2021
|
374 |
402,889
|
MSFT, ARKQ, AAPL, JPM
|
13F-HR
|
7/27/2021 |
000135252621000003 |
|
Q1 2021
|
385 |
403,277
|
TOTL, MSFT, ARKQ, CSX
|
13F-HR
|
4/14/2021 |
000135252621000002 |
|
Q4 2020
|
351 |
376,781
|
TOTL, MSFT, ARKQ, AAPL
|
13F-HR
|
2/3/2021 |
000135252621000001 |
|
Q3 2020
|
323 |
336,842
|
TOTL, MSFT, ARKQ, AAPL
|
13F-HR
|
10/16/2020 |
000135252620000004 |
|
Q2 2020
|
339 |
312,605
|
TOTL, MSFT, ARKQ, CSX
|
13F-HR
|
7/23/2020 |
000135252620000003 |
|
Q1 2020
|
345 |
250,158
|
TOTL, MSFT, FLRN, JPM
|
13F-HR
|
5/1/2020 |
000135252620000002 |
|
Q4 2019
|
339 |
320,037
|
JPM, FLRN, MSFT, CSX
|
13F-HR
|
1/28/2020 |
000135252620000001 |
|
Q3 2019
|
357 |
299,773
|
JPM, FLRN, CSX, MSFT
|
13F-HR
|
10/28/2019 |
000135252619000004 |
|
Q2 2019
|
361 |
299,618
|
FLRN, JPM, CSX, FBT
|
13F-HR
|
8/1/2019 |
000135252619000003 |
|
Q1 2019
|
364 |
292,653
|
FLRN, CSX, FBT, JPM
|
13F-HR
|
5/8/2019 |
000135252619000002 |
|
Q4 2018
|
397 |
261,765
|
FLRN, JPM, CSX, FBT
|
13F-HR
|
2/4/2019 |
000135252619000001 |
|
Q3 2018
|
404 |
295,306
|
FLRN, FBT, JPM, CSX
|
13F-HR
|
11/1/2018 |
000135252618000007 |
|
Q2 2018
|
403 |
280,787
|
FLRN, FBT, JPM, CSX
|
13F-HR
|
8/10/2018 |
000135252618000006 |
|
Q1 2018
|
350 |
197,516
|
T Rowe Price Global Technology Fund, FLRN, FBT, ARKQ
|
13F-HR
|
4/10/2018 |
000135252618000004 |
|
Q4 2017
|
341 |
203,772
|
T Rowe Price Global Technology Fund, FBT, FLRN, ARKQ
|
13F-HR
|
1/16/2018 |
000135252618000002 |
|
Q3 2017
|
388 |
197,099
|
T Rowe Price Global Technology Fund, FBT, FLRN, ARKQ
|
13F-HR
|
10/16/2017 |
000135252617000008 |
|
Q2 2017
|
366 |
222,559
|
Goldman Sachs Strategic Income Fund Inst, T Rowe Price Global Technology Fund, FBT, FLRN
|
13F-HR
|
7/28/2017 |
000135252617000006 |
|
Q1 2017
|
344 |
165,932
|
FLRN, ARKQ, JPM, DIS
|
13F-HR
|
4/19/2017 |
000135252617000004 |
|
Q4 2016
|
317 |
168,702
|
FBT, TPINX, JPM, CVS
|
13F-HR
|
2/13/2017 |
000135252617000002 |
|
Q3 2016
|
322 |
164,634
|
FBT, T Rowe Price Global Technology Fund, CVS, ARKQ
|
13F-HR
|
10/25/2016 |
000135252616000016 |
|
Q2 2016
|
307 |
166,175
|
CVS, FBT, BMY, PFF
|
RESTATEMENT
|
7/15/2016 |
000135252616000014 |
|
Q1 2016
|
302 |
160,793
|
CVS, FBT, BMY, T Rowe Price Global Technology Fund
|
13F-HR
|
4/20/2016 |
000135252616000011 |
|
Q4 2015
|
277 |
160,156
|
FBT, CVS, BMY, T Rowe Price Global Technology Fund
|
13F-HR
|
1/28/2016 |
000135252616000010 |
|
Q3 2015
|
259 |
149,692
|
FBT, CVS, BMY, DIS
|
13F-HR
|
10/28/2015 |
000135252615000008 |
|
Q2 2015
|
277 |
171,159
|
FBT, CVS, UTX, BMY
|
13F-HR
|
7/7/2015 |
000135252615000006 |
|
Q1 2015
|
107 |
162,735
|
FBT, CVS, UTX, BMY
|
13F-HR
|
4/13/2015 |
000135252615000004 |
|
Q4 2014
|
258 |
162,304
|
CVS, FBT, UTX, BMY
|
13F-HR
|
2/9/2015 |
000135252615000002 |
|
Q3 2014
|
284 |
166,882
|
FBT, CVS, UTX, EMC
|
13F-HR
|
10/29/2014 |
000135252614000007 |
|
Q2 2014
|
286 |
165,019
|
FBT, UTX, CVS, CVX
|
13F-HR
|
8/5/2014 |
000135252614000006 |
|
Q1 2014
|
270 |
152,903
|
UTX, CVS, FBT, BMY
|
13F-HR
|
5/7/2014 |
000135252614000004 |
|
Q4 2013
|
255 |
154,115
|
UTX, CVS, FBT, BMY
|
13F-HR
|
1/31/2014 |
000135252614000002 |